EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Update of Natural Compounds in Transthyretin Amyloidosis, Years 2020–2025

Carlo Marotta, Lidia Ciccone, Susanna Nencetti

Crystals · 30.07.2025 · 15 (8) · 696

DOI: 10.3390/cryst15080696 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Crystals, online erschienen am 30.07.2025. Verfasst von Carlo Marotta und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of University and Research.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transthyretin amyloidosis (ATTR) is a disease caused by the deposition of transthyretin-derived fibrils in the body. Despite extensive research conducted over the years, there are currently only four drugs available in clinical use to treat this condition, two of which are repurposed drugs used off-label. However, these treatments present several limitations; therefore, there is an urgent need for new therapeutic options. In this context, dietary supplements containing natural compounds capable of stabilizing the transthyretin (TTR) protein could represent a promising approach to contrast the disease progression, potentially supporting the therapeutic effects of the aforementioned drugs. In light of this, the present review highlights and analyzes the natural compounds that have most recently been reported in the literature as TTR stabilizers. In particular, the studies elucidating the potential of these compounds in the treatment of ATTR, along with the available crystallographic data explaining their binding mode to TTR, are reported. Overall, although the use of natural compounds as supplements shows promise in managing ATTR, further research is still needed to explore its feasibility and confirm its effectiveness. Hopefully, this work will help shed light on these issues and serve as a useful starting point for the development of new strategies to treat this disease.

Förderung

  • Italian Ministry of University and Research

Zitieren

APA

Marotta, C., Ciccone, L., & Nencetti, S. (2025). Update of Natural Compounds in Transthyretin Amyloidosis, Years 2020–2025. Crystals, 15(8), 696. https://doi.org/10.3390/cryst15080696

Vancouver

Marotta C, Ciccone L, Nencetti S. Update of Natural Compounds in Transthyretin Amyloidosis, Years 2020–2025. Crystals. 2025;15(8):696. doi:10.3390/cryst15080696

BibTeX
@article{Marotta2025,
  author = {Marotta, Carlo and Ciccone, Lidia and Nencetti, Susanna},
  title = {Update of Natural Compounds in Transthyretin Amyloidosis, Years 2020–2025},
  journal = {Crystals},
  year = {2025},
  volume = {15},
  number = {8},
  pages = {696},
  doi = {10.3390/cryst15080696}
}
Kostenlos starten →